Cargando…

Short term survival of critically ill COVID-19 Egyptian patients on assisted ventilation treated by either Dexamethasone or Tocilizumab

Tocilizumab (TCZ) and Dexamethasone are used for the treatment of critically ill COVID-19 patients. We compared the short-term survival of critically ill COVID-19 patients treated with either TCZ or Dexamethasone. 109 critically ill COVID-19 patients randomly assigned to either TCZ therapy (46 patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rashad, Alaa, Mousa, Sherif, Nafady-Hego, Hanaa, Nafady, Asmaa, Elgendy, Hamed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065149/ https://www.ncbi.nlm.nih.gov/pubmed/33893337 http://dx.doi.org/10.1038/s41598-021-88086-x

Ejemplares similares

Analysis of Bacterial and Fungal Infections after Cytoreduction Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Observational Single-Centre Study
por: Albukhari, Talat A. M., et al.
Publicado: (2019)

Perioperative management and postoperative outcome of patients undergoing cytoreduction surgery with hyperthermic intraperitoneal chemotherapy
por: Elgendy, Hamed, et al.
Publicado: (2019)

Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker
por: Zahran, Asmaa M., et al.
Publicado: (2021)

Corrigendum: Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker
por: Zahran, Asmaa M., et al.
Publicado: (2022)

Therapeutic efficacy of macrolides in management of patients with mild COVID-19
por: Rashad, Alaa, et al.
Publicado: (2021)

SARS-CoV-2 infection in 3,241 School working staffs: Impact of SARS CoV-2 variants of concern [Wild, B.1.1.7 and Omicron]
por: Alishaq, Moza, et al.
Publicado: (2023)

Increased percentage of apoptotic and CTLA-4 (CD152) expressing cells in CD4(+)/CD8(+) cells in COVID-19 patients
por: Zahran, Asmaa M., et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 Infection Among Working Women and Impact of Workplace Restrictions
por: Alishaq, Moza, et al.
Publicado: (2022)

SARS-CoV-2 PCR and antibody positivity among school staff at the beginning and end of the first school term
por: Alishaq, Moza, et al.
Publicado: (2021)

Peripheral Mononuclear Cells Surface Markers Evaluation in Different Stages of Hepatocellular Carcinoma; in a Trial for Early and Accurate Diagnosis in Patients with Post-Hepatitis Liver Cirrhosis and Unremarkable Raised AFP
por: Osman, Heba Ahmed, et al.
Publicado: (2023)

Prognostic Role of Monocytic Myeloid-Derived Suppressor Cells in Advanced Non-Small-Cell Lung Cancer: Relation to Different Hematologic Indices
por: Zahran, Asmaa M., et al.
Publicado: (2021)

Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workers
por: Alishaq, Moza, et al.
Publicado: (2021)

Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2019)

The utility of CRP with the use of dexamethasone and Tocilizumab in critically ill patients with COVID-19
por: Zacharias, Harry, et al.
Publicado: (2022)

Is Tocilizumab Plus Dexamethasone Associated with Superinfection in Critically Ill COVID-19 Patients?
por: Camou, Fabrice, et al.
Publicado: (2022)

Comparative Effectiveness of Tocilizumab with either Methotrexate or Leflunomide in the Treatment of Rheumatoid Arthritis
por: Narváez, Javier, et al.
Publicado: (2015)

Dexamethasone/methylprednisolone/tocilizumab: Candidaemia: case report
Publicado: (2021)

Dexamethasone/remdesivir/tocilizumab: Various toxicities: case report
Publicado: (2022)

Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?
por: Gupta, Rahul
Publicado: (2022)

Dexamethasone/tocilizumab: Invasive pulmonary aspergillosis: case report
Publicado: (2021)

Dexamethasone/remdesivir/tocilizumab: Lack of efficacy: case report
Publicado: (2022)

Utility of a modified distress thermometer in screening COVID-19 patients for psychological distress: a prospective Egyptian study
por: Mohamed, Sherif A.A., et al.
Publicado: (2021)

Dexamethasone/prednisone/tocilizumab: Worsening of Strongyloides infection: case report
Publicado: (2020)

2273. Azithromycin Use Before and During COVID- 19 and Impact of Implementing Evidence-based Guidelines
por: Shams, Sherin, et al.
Publicado: (2023)

Xanthone and lignan glycosides from the aerial parts of Polygonum bellardii all growing in Egypt
por: Abd El-kader, Adel M., et al.
Publicado: (2013)

Negative versus natural drainage after single-level posterior lumbar interbody fusion. A prospective randomized study
por: Elfiky, Tarek, et al.
Publicado: (2022)

Severity-Adjusted Dexamethasone Dosing and Tocilizumab Combination for Severe COVID-19
por: Hong, Jin Yeong, et al.
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Methaemoglobinaemia and off-label use: case report
Publicado: (2021)

Dexamethasone/tocilizumab: Off-label-use and lack of efficacy: case report
Publicado: (2021)

Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination
por: Butt, Adeel A., et al.
Publicado: (2021)

Soluble CD25 as a predictor of hepatocellular carcinoma compared with alpha-fetoprotein
por: Abdelfattah, Shaymaa Nafady, et al.
Publicado: (2019)

The Egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
por: Fouad, Yasser, et al.
Publicado: (2022)

Heavy Metals Can either Aid or Oppose the Protective Function of the Placental Barrier
por: Hameed, Enas R. Abdel, et al.
Publicado: (2019)

Tocilizumab for treatment of mechanically ventilated patients with COVID-19
por: Somers, Emily C, et al.
Publicado: (2020)

Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19
por: Somers, Emily C, et al.
Publicado: (2020)

Use of Tocilizumab May Avoid the Need of Invasive Ventilation
por: Adhikari, Anurag, et al.
Publicado: (2021)

Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodies
por: Kauer, Joseph, et al.
Publicado: (2020)

Dexamethasone/tocilizumab: Lack of efficacy during off label use: case report
Publicado: (2022)

Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease
por: Qutob, Haitham M.H., et al.
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Lack of efficacy and off label use: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lqhkr2m3k2pf0b51t763b6cdra